SanBio Company Limited (4592) Other
Market cap
¥170.1B
P/E ratio
-30.2x
SanBio develops cell therapy drugs to help patients recover brain and nervous system functions lost due to injury or diseases like Parkinson's and Alzheimer's.
| 2014/01 | 2015/01 | 2016/01 | 2017/01 | 2018/01 | 2019/01 | 2020/01 | 2021/01 | 2022/01 | 2023/01 | 2024/01 | 2025/01 | 2026/01 | |
| Return on Assets | - | - | -10.3 | -2 | -13.6 | -14.3 | -12.7 | 10.1 | -16.6 | -60.5 | -12.6 | -17.2 | -11.8 |
| Return on equity (%) | - | - | |||||||||||
| Employees | 12 | 13 | 23 | 37 | 32 | 43 | 74 | 85 | 89 | 65 | 29 | 29 | 33 |